Literature DB >> 28326775

Determining Cysteines Available for Covalent Inhibition Across the Human Kinome.

Zheng Zhao1, Qingsong Liu2, Spencer Bliven1,3, Lei Xie4,5, Philip E Bourne1,6.   

Abstract

Covalently bound protein kinase inhibitors have been frequently designed to target noncatalytic cysteines at the ATP binding site. Thus, it is important to know if a given cysteine can form a covalent bond. Here we combine a function-site interaction fingerprint method and DFT calculations to determine the potential of cysteines to form a covalent interaction with an inhibitor. By harnessing the human structural kinome, a comprehensive structure-based binding site cysteine data set was assembled. The orientation of the cysteine thiol group indicates which cysteines can potentially form covalent bonds. These covalent inhibitor easy-available cysteines are located within five regions: P-loop, roof of pocket, front pocket, catalytic-2 of the catalytic loop, and DFG-3 close to the DFG peptide. In an independent test set these cysteines covered 95% of covalent kinase inhibitors. This study provides new insights into cysteine reactivity and preference which is important for the prospective development of covalent kinase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28326775      PMCID: PMC5493210          DOI: 10.1021/acs.jmedchem.6b01815

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  78 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  The ins and outs of selective kinase inhibitor development.

Authors:  Susanne Müller; Apirat Chaikuad; Nathanael S Gray; Stefan Knapp
Journal:  Nat Chem Biol       Date:  2015-11       Impact factor: 15.040

Review 3.  Tec family kinases Itk and Rlk / Txk in T lymphocytes: cross-regulation of cytokine production and T-cell fates.

Authors:  Julio Gomez-Rodriguez; Zachary J Kraus; Pamela L Schwartzberg
Journal:  FEBS J       Date:  2011-03-29       Impact factor: 5.542

4.  Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of ERK1/2.

Authors:  Richard A Ward; Nicola Colclough; Mairi Challinor; Judit E Debreczeni; Kay Eckersley; Gary Fairley; Lyman Feron; Vikki Flemington; Mark A Graham; Ryan Greenwood; Philip Hopcroft; Tina D Howard; Michael James; Clifford D Jones; Christopher R Jones; Jonathan Renshaw; Karen Roberts; Lindsay Snow; Michael Tonge; Kay Yeung
Journal:  J Med Chem       Date:  2015-05-28       Impact factor: 7.446

5.  Delineation of Polypharmacology across the Human Structural Kinome Using a Functional Site Interaction Fingerprint Approach.

Authors:  Zheng Zhao; Li Xie; Lei Xie; Philip E Bourne
Journal:  J Med Chem       Date:  2016-03-17       Impact factor: 7.446

Review 6.  Advances in kinase targeting: current clinical use and clinical trials.

Authors:  Mathias Rask-Andersen; Jin Zhang; Doriano Fabbro; Helgi B Schiöth
Journal:  Trends Pharmacol Sci       Date:  2014-10-10       Impact factor: 14.819

7.  Ionic liquid as catalyst and reaction medium. The dramatic influence of a task-specific ionic liquid, [bmIm]OH, in Michael addition of active methylene compounds to conjugated ketones, carboxylic esters, and nitriles.

Authors:  Brindaban C Ranu; Subhash Banerjee
Journal:  Org Lett       Date:  2005-07-07       Impact factor: 6.005

8.  A fluorescence-based assay for p38α recruitment site binders: identification of rooperol as a novel p38α kinase inhibitor.

Authors:  Jing Li; Tamer S Kaoud; Jake LeVieux; Brad Gilbreath; Swapna Moharana; Kevin N Dalby; Sean M Kerwin
Journal:  Chembiochem       Date:  2012-12-06       Impact factor: 3.164

9.  KLIFS: a structural kinase-ligand interaction database.

Authors:  Albert J Kooistra; Georgi K Kanev; Oscar P J van Linden; Rob Leurs; Iwan J P de Esch; Chris de Graaf
Journal:  Nucleic Acids Res       Date:  2015-10-22       Impact factor: 16.971

10.  UniProt: the universal protein knowledgebase.

Authors: 
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

View more
  20 in total

1.  A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site Identification.

Authors:  Christopher M Browne; Baishan Jiang; Scott B Ficarro; Zainab M Doctor; Jared L Johnson; Joseph D Card; Sindhu Carmen Sivakumaren; William M Alexander; Tomer M Yaron; Charles J Murphy; Nicholas P Kwiatkowski; Tinghu Zhang; Lewis C Cantley; Nathanael S Gray; Jarrod A Marto
Journal:  J Am Chem Soc       Date:  2018-12-20       Impact factor: 15.419

Review 2.  Advances of small molecule targeting of kinases.

Authors:  Norbert Berndt; Rezaul M Karim; Ernst Schönbrunn
Journal:  Curr Opin Chem Biol       Date:  2017-07-18       Impact factor: 8.822

Review 3.  Selective and Effective: Current Progress in Computational Structure-Based Drug Discovery of Targeted Covalent Inhibitors.

Authors:  Giulia Bianco; David S Goodsell; Stefano Forli
Journal:  Trends Pharmacol Sci       Date:  2020-11-02       Impact factor: 14.819

4.  Leveraging Compound Promiscuity to Identify Targetable Cysteines within the Kinome.

Authors:  Suman Rao; Deepak Gurbani; Guangyan Du; Robert A Everley; Christopher M Browne; Apirat Chaikuad; Li Tan; Martin Schröder; Sudershan Gondi; Scott B Ficarro; Taebo Sim; Nam Doo Kim; Matthew J Berberich; Stefan Knapp; Jarrod A Marto; Kenneth D Westover; Peter K Sorger; Nathanael S Gray
Journal:  Cell Chem Biol       Date:  2019-04-11       Impact factor: 8.116

Review 5.  Reactivity-based chemical-genetic study of protein kinases.

Authors:  Renata Rezende Miranda; Chao Zhang
Journal:  RSC Med Chem       Date:  2022-03-30

6.  Δ-Quantum machine-learning for medicinal chemistry.

Authors:  Kenneth Atz; Clemens Isert; Markus N A Böcker; José Jiménez-Luna; Gisbert Schneider
Journal:  Phys Chem Chem Phys       Date:  2022-05-11       Impact factor: 3.945

7.  Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells.

Authors:  Daniel M Foulkes; Dominic P Byrne; Wayland Yeung; Safal Shrestha; Fiona P Bailey; Samantha Ferries; Claire E Eyers; Karen Keeshan; Carrow Wells; David H Drewry; William J Zuercher; Natarajan Kannan; Patrick A Eyers
Journal:  Sci Signal       Date:  2018-09-25       Impact factor: 8.192

8.  Structural Insights into Characterizing Binding Sites in Epidermal Growth Factor Receptor Kinase Mutants.

Authors:  Zheng Zhao; Lei Xie; Philip E Bourne
Journal:  J Chem Inf Model       Date:  2019-01-11       Impact factor: 4.956

9.  Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis.

Authors:  Tom van der Wel; Riet Hilhorst; Hans den Dulk; Tim van den Hooven; Nienke M Prins; Joost A P M Wijnakker; Bogdan I Florea; Eelke B Lenselink; Gerard J P van Westen; Rob Ruijtenbeek; Herman S Overkleeft; Allard Kaptein; Tjeerd Barf; Mario van der Stelt
Journal:  Nat Commun       Date:  2020-06-25       Impact factor: 14.919

Review 10.  Kinase-targeted cancer therapies: progress, challenges and future directions.

Authors:  Khushwant S Bhullar; Naiara Orrego Lagarón; Eileen M McGowan; Indu Parmar; Amitabh Jha; Basil P Hubbard; H P Vasantha Rupasinghe
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.